4-hydroxyclomiphene has been researched along with calmidazolium in 1 studies
*calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin [MeSH]
*calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin [MeSH]
| Studies (4-hydroxyclomiphene) | Trials (4-hydroxyclomiphene) | Recent Studies (post-2010) (4-hydroxyclomiphene) | Studies (calmidazolium) | Trials (calmidazolium) | Recent Studies (post-2010) (calmidazolium) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 550 | 0 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musgrove, EA; Sutherland, RL; Wakeling, AE | 1 |
1 other study(ies) available for 4-hydroxyclomiphene and calmidazolium
| Article | Year |
|---|---|
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Topics: Breast Neoplasms; Calmodulin; Cell Cycle; Clomiphene; DNA; Estradiol; Estrogen Antagonists; Female; Humans; Imidazoles; Polyunsaturated Alkamides; Tumor Cells, Cultured | 1989 |